首页 > 市场调查报告书 > 医疗设备

手术用器具

市场调查报告书

商品编码

1606555

日本手术设备市场 - 2024-2031

Japan Surgical Equipments Market - 2024-2031

出版日期: 2024年12月04日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

日本手术设备市场2023年达到8.5982亿美元，预计到2031年将达到17.2348亿美元，2024-2031年预测期间复合年增长率为10.6%。

日本手术设备市场包括各种各样的设备和仪器，这些设备和仪器对于跨多个医学专业进行外科手术至关重要。该市场的特点是有几个关键产品类别。手持器械，如镊子、剪刀、手术刀、牵开器、扩张器、抓紧器和辅助工具，构成了外科手术的支柱。这些仪器对于抓取组织、进行精确切割以及在手术期间提供可视性等任务至关重要。此外，电外科设备透过使用电能切割和凝固组织发挥至关重要的作用，这有助于最大限度地减少失血并提高手术过程中的精确度。

此外，市面上还有专为微创手术设计的腹腔镜工具。套管针和腹腔镜等仪器允许外科医生透过小切口进行手术，从而缩短患者的恢復时间并减少术后疼痛。最后，伤口闭合装置，包括缝线和吻合器，对于手术后有效闭合切口或伤口、确保正常癒合至关重要。这些不同产品类型的结合凸显了手术设备市场在促进传统和微创手术技术、最终改善日本医疗保健系统患者治疗效果的重要性。这些因素推动了日本手术设备市场的扩张。

市场动态：

驱动程式和限制

对微创手术的需求不断增长

对微创手术的需求不断增长，极大地推动了日本手术设备市场的成长，预计将在整个市场预测期内推动成长。

对微创手术 (MIS) 的需求不断增长是日本手术设备市场的关键驱动力，受到提高患者治疗效果和整体医疗效率的多种因素的影响。微创手术的特征是切口较小，减少了传统开放性手术带来的创伤。这种方法可以缩短復健时间、减少术后疼痛并降低併发症风险，从而缩短住院时间，这是优先考虑效率和成本效益的医疗保健系统的重要考虑因素。

根据世界经济论坛2023年9月发表的文章，目前日本超过10%的人口年龄在80岁以上，而总人口中约33.33%年龄在65岁以上。这一重大的人口变化表明存在大量潜在患者，预计这将增加该国对手术设备的需求。

在日本，人口老化在很大程度上导致了对 MIS 的偏好不断上升，因为老年人更有可能需要对慢性病进行手术干预。大约 33% 的人口年龄在 65 岁或以上，这对有效但侵入性较小的手术解决方案产生了巨大的需求。此外，机器人辅助系统和增强成像技术等手术技术的进步透过提高手术精度和结果进一步支持了这一趋势。随着医疗保健提供者越来越多地采用这些创新技术，针对微创手术量身定制的专业手术设备的需求预计将会上升，从而推动市场的成长。这种转变不仅反映了外科手术实践的不断发展，而且与更广泛的医疗保健目标一致，旨在加强患者护理，同时有效管理成本。

此外，产业主要参与者推出的产品将推动日本手术设备市场的成长。例如，2022 年 2 月，施乐辉在日本推出了 CORI 手术系统，标誌着手术器械领域的重大飞跃，特别是膝关节置换术。这项创新产品旨在提高手术准确性并改善患者治疗效果，顺应微创手术技术日益增长的趋势。

此外，奥林巴斯公司于2022 年9 月推出了VISERA ELITE III，这是一个尖端的手术可视化平台，专为满足参与不同医学学科内视镜手术的医疗保健专业人员(HCP) 的需求而量身定制。这项创新系统旨在透过将多种先进影像功能整合到一个平台中，增强腹腔镜结肠切除术和腹腔镜胆囊切除术等微创手术的能力。

此外，日本国内新兴市场需求的不断成长也有助于日本手术设备市场的扩张。

严格的政府法规

严格的政府法规是日本手术设备市场的重大限制，影响医疗设备的开发、批准和行销。监管架构由药品和医疗器材管理局 (PMDA) 以及厚生劳动省 (MHLW) 管辖，它们执行严格的标准，以确保医疗产品在上市前的安全性和有效性。

在日本获得手术设备批准的途径非常复杂且耗时。医疗器材依相关风险等级分为四类（I 类至 IV 类），风险较高的器材需要接受更严格的评估。例如，对患者风险最高的 IV 类器械在进入市场之前必须通过 PMDA 的全面评估。这种复杂性可能会导致产品发布延迟并增加製造商的成本。

寻求在日本销售设备的外国公司必须获得外国製造商註册 (FMR) 证书。此过程需要全面的文件记录并遵守当地法规，这对于不熟悉日本监管环境的人来说尤其具有挑战性。此外，所有提交的文件都必须翻译成日语，这又增加了一层复杂性。因此，上述因素可能限制日本手术设备市场的潜在成长。

The Japan surgical equipment market includes a wide variety of devices and instruments that are critical for performing surgical procedures across multiple medical specialties. This market is characterized by several key categories of products. Handheld instruments, such as forceps, scissors, scalpels, retractors, dilators, graspers, and auxiliary tools, form the backbone of surgical operations. These instruments are essential for tasks like grasping tissues, making precise cuts, and providing visibility during surgery. Additionally, electrosurgical devices play a vital role by using electrical energy to cut and coagulate tissue, which helps minimize blood loss and enhances precision during procedures.

Furthermore, the market features laparoscopic tools, specifically designed for minimally invasive surgeries. Instruments like trocars and laparoscopes allow surgeons to perform operations through small incisions, leading to quicker recovery times and reduced postoperative pain for patients. Lastly, wound closure devices, including sutures and staplers, are crucial for effectively closing incisions or wounds after surgery, ensuring proper healing. The combination of these diverse product types underscores the importance of the surgical equipment market in facilitating both traditional and minimally invasive surgical techniques, ultimately improving patient outcomes in Japan's healthcare system. These factors have driven Japan surgical equipments market expansion.

Market Dynamics: Drivers & Restraints

Rising Demand for Minimally Invasive Surgical Procedures

The rising demand for minimally invasive surgical procedures is significantly driving the growth of the Japan surgical equipments market and is expected to drive throughout the market forecast period.

The increasing demand for minimally invasive surgical procedures (MIS) is a key driver in the Japan surgical equipment market, influenced by several factors that enhance patient outcomes and overall healthcare efficiency. Minimally invasive surgeries are characterized by smaller incisions, which reduce the trauma associated with traditional open surgeries. This approach leads to quicker recovery times, less postoperative pain, and a lower risk of complications, resulting in shorter hospital stays an essential consideration in a healthcare system that prioritizes efficiency and cost-effectiveness.

According to an article published by the World Economic Forum in September 2023, more than 10% of Japan's population is now aged 80 or older, while approximately 33.33% of the total population is 65 years or older. This significant demographic shift indicates a large potential patient pool, which is expected to drive up the demand for surgical equipment in the country.

In Japan, the aging population significantly contributes to the rising preference for MIS, as older individuals are more likely to require surgical interventions for chronic conditions. Approximately 33% of the population is aged 65 or older, creating a substantial demand for effective yet less invasive surgical solutions. Additionally, advancements in surgical technologies, such as robotic-assisted systems and enhanced imaging techniques, further support this trend by improving precision and outcomes during surgeries. As healthcare providers increasingly adopt these innovative techniques, the demand for specialized surgical equipment tailored for minimally invasive procedures is expected to rise, driving growth in the market. This shift not only reflects evolving surgical practices but also aligns with broader healthcare goals aimed at enhancing patient care while managing costs effectively.

Furthermore, key players in the industry product launches that would drive this Japan surgical equipment market growth. For instance, in February 2022, Smith & Nephew introduced the CORI Surgical System in Japan marking a significant leap forward in the surgical devices sector, especially for knee arthroplasty procedures. This innovative product aims to improve surgical accuracy and enhance patient outcomes, aligning with the increasing trend toward minimally invasive surgical techniques.

Also, in September 2022, Olympus Corporation launched the VISERA ELITE III, a cutting-edge surgical visualization platform tailored to meet the needs of healthcare professionals (HCPs) involved in endoscopic procedures across various medical disciplines. This innovative system is designed to enhance the capabilities of minimally invasive surgeries, such as laparoscopic colectomy and laparoscopic cholecystectomy, by integrating multiple advanced imaging functions into a single platform.

Moreover, the rising demand for emerging markets within Japan contributes to Japan surgical equipment market expansion.

Stringent Government Regulations

Stringent government regulations act as a significant constraint in the Japan surgical equipment market, influencing the development, approval, and marketing of medical devices. The regulatory framework is governed by the Pharmaceutical and Medical Devices Agency (PMDA) and the Ministry of Health, Labor, and Welfare (MHLW), which enforce rigorous standards to ensure the safety and efficacy of medical products before they can be marketed.

The pathway to obtaining approval for surgical equipment in Japan is intricate and can be time-consuming. Medical devices are categorized into four classes based on their associated risk levels (Class I to Class IV), with higher-risk devices undergoing more stringent evaluations. For instance, Class IV devices, which present the highest risk to patients, must pass a thorough assessment by the PMDA before market entry. This complexity can lead to delays in product launches and increased costs for manufacturers.

Foreign companies seeking to sell their devices in Japan must secure a Foreign Manufacturer Registration (FMR) certificate. This process entails comprehensive documentation and compliance with local regulations, which can be particularly challenging for those unfamiliar with Japan's regulatory landscape. Furthermore, all submitted documents must be translated into Japanese, adding another layer of complexity. Thus, the above factors could be limiting the Japan surgical equipments market's potential growth.

Segment Analysis

The Japan surgical equipments market is segmented based on product type, category, application, and end-user.

Product Type:

The wound closure devices segment is expected to dominate the Japan surgical equipments market share

The wound closure devices segment holds a major portion of the Japan surgical equipments market share and is expected to continue to hold a significant portion of the Japan surgical equipments market share during the forecast period.

The wound closure devices segment within the Japanese surgical equipment market is vital for ensuring effective surgical outcomes by properly closing incisions and wounds. This segment primarily consists of surgical sutures and staplers, both of which are crucial for facilitating healing and minimizing complications after surgery.

Surgical sutures are threads used to stitch tissues together following an incision or injury. They are available in various types, including absorbable and non-absorbable materials, enabling surgeons to select the most suitable option based on the specific needs of the procedure and the patient's condition. Sutures are widely utilized across multiple surgical specialties, such as general surgery, orthopedic surgery, and gynecology.

Furthermore, key player's strategies such as partnerships and collaborations would drive this segment growth in the Japan surgical equipments market growth. For instnace, in August 2023, Asensus Surgical, Inc. announced a significant partnership with First Towakai Hospital to lease and utilize its Senhance Surgical System in their urology and gynecology centers, as well as the gastroenterology department. This collaboration highlights the growing trend of integrating advanced robotic surgical systems into healthcare facilities to enhance surgical capabilities and patient outcomes.

Also, in January 2023, MiMedx Group, Inc. announced an exclusive distribution agreement with Gunze Medical Limited, a subsidiary of Gunze Limited, to facilitate the sales of its product EPIFIX in Japan. This partnership is significant as Gunze Medical is a prominent distributor of medical products used in various wound and surgical settings, including bioabsorbable devices and materials such as sutures and sheet products. These factors have solidified the segment's position in the Japan surgical equipments market.

Competitive Landscape

The major players in the Japan surgical equipments market include Olympus, Terumo Corporation, B. Braun SE, Medtronic, CONMED Corporation., Smith+Nephew, Johnson & Johnson Services, Inc., Boston Scientific Corporation, Stryker, and Aspen Surgical Products, Inc. among others.

Key Developments

In September 2024, Olympus Corporation announced the launch of its new 4K camera head, designated CH-S700-08-LB, specifically designed for endoscopic urology and gynecology procedures. This product is compatible with the VISERA ELITE III video system center, which is a comprehensive platform for surgical endoscopy. The camera head will initially be introduced in Europe and is set to launch in Japan, Hong Kong, and Singapore, pending compliance with local regulations.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Japan surgical equipment's market report delivers a detailed analysis with 40+ key tables, more than 30 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Category & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Category
3.3. Snippet by Application
3.4. Snippet by End-User

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rising Demand for Minimally Invasive Surgical Procedures and
- 4.1.2. Restraints
  - 4.1.2.1. Stringent Government Regulations
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Patent Analysis
5.5. Regulatory Analysis
5.6. SWOT Analysis
5.7. Unmet Needs

6. By Product Type

6.1. Introduction
- 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. Handheld Devices*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 6.2.3. Forceps
- 6.2.4. Scissors
- 6.2.5. Scalpels
- 6.2.6. Retractors
- 6.2.7. Dilators
- 6.2.8. Graspers
- 6.2.9. Auxiliary instruments
6.3. Laparoscopic Devices
- 6.3.1. Trocars and access devices
- 6.3.2. Laparoscopes
6.4. Electrosurgical Devices
6.5. Wound Closure Devices
- 6.5.1. Sutures
- 6.5.2. Staplers
6.6. Others

7. By Category

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
- 7.1.2. Market Attractiveness Index, By Category
7.2. Reusable Surgical Equipment*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Disposable Surgical Equipment

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Gynecology and Urology*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Cardiology
8.4. Orthopedics
8.5. Neurology
8.6. Others

9. By End-User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals *
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Specialty Clinics
9.4. Ambulatory Surgical Centers
9.5. Others

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. Olympus*
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Terumo Corporation
11.3. B. Braun SE
11.4. Medtronic
11.5. CONMED Corporation.
11.6. Smith+Nephew
11.7. Johnson & Johnson Services, Inc.
11.8. Boston Scientific Corporation
11.9. Stryker
11.10. Aspen Surgical Products, Inc.

LIST NOT EXHAUSTIVE